Nymox Pharmaceutical Corp (NASDAQ:NYMX)

1.54
Delayed Data
As of 1:03pm ET
 0.00 / 0.00%
Today’s Change
0.33
Today|||52-Week Range
5.75
+285.00%
Year-to-Date
No recent news for Nymox Pharmaceutical Corp.

Today’s Trading

Previous close1.54
Today’s open1.56
Day’s range1.53 - 1.59
Volume98,874
Average volume (3 months)1,619,799
Market cap$57.3M
Dividend yield--
Data as of 1:03pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)+7.14%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-12.19%
P/E ratioNM
Price/Sales4.78
Price/Book--

Competitors

 Today’s
change
Today’s
% change
APDNApplied DNA Sciences...-0.00-0.17%
ENZNEnzon Pharmaceutical...-0.04-3.03%
MTEXMannatech Inc+0.08+0.40%
JAGXJaguar Animal Health...-0.22-3.20%
Data as of 1:11pm ET, 05/29/2015

Financials

Next reporting dateAugust 14, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$2.9M
Annual profit (last year)-$4.6M
Net profit margin-155.76%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer, Secretary &
Treasurer
André Monette
Corporate headquarters
Saint-Laurent, Quebec

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers